ArticleApplied clinical informatics2025
Challenges to Reduce Alert Burden Using Current Decision Support Infrastructure in Two Commercial EHR Systems: Lessons Learned and Path Forward.
Article in Applied clinical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Identifying false-positive drug allergy alerts based on drug tolerance assertions: a retrospective study.JAMIA open · 2026Article
- Transforming nephrology through artificial intelligence: a state-of-the-art roadmap for clinical integration.Clinical kidney journal · 2026Review
- In pursuit of the alert fatigue: an assessment of drug alert burden at a large academic medical center.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the proven usefulness of appropriate clinical decision support (CDS) alerts, many CDS systems fire excessive, clinically irrelevant alerts that are often ignored by clinicians. We have developed a method to suppress false-positive alerts based on prior drug tolerance but encountered substantial barriers to integrating the method into widely adopted commercial electronic health record (EHR) systems.This study aimed to describe the challenges faced while attempting to integrate our method into the CDS infrastructure of two commercial EHR systems and provide recommendations for future research and CDS design.Using a multifaceted approach, we investigated (1) the use of emergent CDS standards (e.g., CDS Hooks) to create a scalable solution to augment off-the-shelf EHR-based alerts with patient-specific custom alerts, (2) customize CDS rules of commercial medication knowledge bases (MKBs) to reduce false-positive alerts, and (3) manually inactivate allergy documentation in patients with prior drug tolerance.We were unable to implement the standards-based approach because support for CDS Hooks was found to be tailored to specific scenarios that involve the creation of new drug allergy alerts (DAAs) but not the suppression of vendor-supplied DAAs. Likewise, we were unable to suppress alerts imported from MKBs into the EHR systems investigated because these systems do not support discrete clinical documentation changes that drive DAAs. Lastly, we determined that although manually inactivating allergy documentation in patients with prior drug tolerance is possible, doing so requires the impractical solution of creating and maintaining individual rules for each drug at the ingredient level.We describe the barriers that precluded implementation of a novel method to suppress clinically irrelevant CDS alerts in two commercial EHR systems. Overcoming these barriers will require a more flexible CDS infrastructure, as well as collaboration and shared responsibility across diverse stakeholders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.